The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II clinical study of adebrelimab and bevacizumab combined with cisplatin/carboplatin in triple-negative breast cancer patients with brain metastases.
 
Ting Li
No Relationships to Disclose
 
Biyun Wang
No Relationships to Disclose
 
Zhonghua Tao
No Relationships to Disclose
 
Mingchuan Zhao
No Relationships to Disclose
 
Leiping Wang
No Relationships to Disclose
 
Juan Jin
No Relationships to Disclose
 
Yannan Zhao
No Relationships to Disclose
 
Chengcheng Gong
No Relationships to Disclose
 
Jun Cao
No Relationships to Disclose
 
Haitao Miao
No Relationships to Disclose
 
Jianfei Wang
Employment - Jiangsu Hengrui Pharmaceuticals Co., Ltd,
 
Xichun Hu
Honoraria - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Hengrui Pharmaceutical; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca
 
Jian Zhang
No Relationships to Disclose